A new model for drug discovery – meeting our societal obligation
- 15 March 2003
- journal article
- editorial
- Published by Elsevier in Drug Discovery Today
- Vol. 8 (6) , 245-248
- https://doi.org/10.1016/s1359-6446(02)02594-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease SusceptibilityCell, 2002
- Insulin-degrading enzyme: embarking on amyloid destructionTrends in Biochemical Sciences, 2001
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Screen idols: faster, smaller, cheaper and smarterTrends in Biotechnology, 2000
- A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptorNature Genetics, 1999
- Amyloid Formation by Mutant Huntingtin: Threshold, Progressivity and Recruitment of Normal Polyglutamine ProteinsSomatic Cell and Molecular Genetics, 1998